Full-Time

Associate Director

Medical Writing

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for genetic diseases

Biotechnology
Healthcare

Compensation Overview

$160k - $185kAnnually

Mid, Senior

Pasadena, CA, USA + 1 more

More locations: San Diego, CA, USA

Category
Technical Writing
Content & Writing
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree in medically related field or life science
  • 6 to 8 years of relevant medical writing experience in the pharmaceutical industry is essential
  • Must have a thorough knowledge of clinical research concepts, practices, and FDA regulations and ICH Guidelines regarding drug development phases, clinical research and medical writing standards; demonstrated ability to interpret and apply these guidelines to document writing. Familiarity with basic statistical analysis concepts and techniques is required
  • A demonstrated track record of contribution to successful regulatory components used in filings eg, IND/CTAs, NDA/BLA/MAAs is important
  • Prior experience in interacting with cross-functional study team members is essential
  • Highly proficient in the use of MS Word, Excel, Endnote, Adobe Acrobat, PowerPoint, and structured document templates
Responsibilities
  • Prepares, edits, and finalizes protocols, investigator brochures, synopses, clinical study reports, regulatory documents (INDs/NDAs, annual reports, Orphan Drug Designation applications, Agency Response to Questions, briefing books, etc)
  • Prepares related clinical documents, such as abstracts, posters, presentations, and manuscripts
  • Collaborates with and manages contract medical writers as required for project assignments
  • Advises and assists in the review and management of nonclinical and CMC technical reports as required
  • Develops and maintains company house-standard templates and best review practices for regulatory and clinical documentation. Ensure vendors and contractors maintain company standards
  • Participates in regulatory and clinical team strategy meetings to ensure that that results and messages in clinical documents accurately reflect the data in tables, figures, and listings (TFLs) and other information sources Partners with the scientific staff including participation in the review of mock and/or blinded TFLs, and narrative planning for relevant documents
  • Assists in the development and maintenance of Development Core Product Data Sheets, draft labeling, and company work instructions and SOPs, as requested
  • Ensures that medical writing deliverables conform to International Conference on Harmonization (ICH) and other relevant regulatory guidelines and medical editorial boards
  • Manages the document review process ensuring conflicting and/or ambiguous comments are clarified and appropriately addressed. Schedules and conducts document-related meetings including kickoff meetings and document review planning and alignment discussions to ensure documentation timelines are achieved
  • Ensures documents are generated in accordance with agreed internal processes and standards, are submission ready, and are appropriately stored in appropriate document management system(s)
  • Ensures that appropriate documented quality control (QC) checks are performed on regulatory/medical writing deliverables, responds to findings, and recommends quality process improvements
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse the progression of diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure deep and lasting effects on target genes. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. Their goal is to provide new options for patients suffering from genetic disorders, and they generate revenue through partnerships, licensing agreements, and future sales of their therapies after regulatory approval.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's recent $450 million funding round provides substantial financial resources to advance its drug pipeline and expand research initiatives.
  • Positive Phase 2 data for plozasiran and the initiation of an Expanded Access Program highlight the company's commitment to addressing unmet medical needs.
  • The company's diversified pipeline, including treatments for cystic fibrosis, hepatitis B, and myotonic dystrophy, offers multiple avenues for success.

What critics are saying

  • The high costs and lengthy timelines associated with drug development could strain Arrowhead's financial resources despite recent funding.
  • Regulatory hurdles and the potential for clinical trial failures pose significant risks to the company's drug approval process.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead Pharmaceuticals leverages RNA interference (RNAi) technology to target and silence disease-causing genes, setting it apart from traditional pharmaceutical approaches.
  • The company's proprietary TRiM platform enables tissue-specific targeting, enhancing the efficacy and safety of its therapies.
  • Strategic partnerships with major pharmaceutical companies like Takeda bolster Arrowhead's credibility and expand its research capabilities.

Help us improve and share your feedback! Did you find this helpful?